James D. Clelland - Concepedia

Author

James D. Clelland

Nathan Kline Institute for Psychiatric Research ORCID

Also Known As

Clelland, James D, J Clelland, J D Clelland, J. D. CLELLAND, JAMES D. CLELLAND, James Clelland, James D Clelland, James D. Clelland

Publications

909

Citations

H-Index

Concepts

All Affiliations

Nathan Kline Institute for Psychiatric Research Columbia University Irving Medical Center New York State Office of Mental Health NYU Langone Health New York University

About

James D. Clelland is an author at Nathan Kline Institute for Psychiatric Research specializing in medicine, psychiatry, and biological psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	304
2	Social Sciences	4	4	118
3	Biochemistry	4	4	80
4	Natural Sciences	2	2	33
5	Biostatistics	1	1	40

James D. Clelland

Publications

856

Citations

H-Index

Page 1

	Year	Citations
Cell-Matrix Adhesions Differentially Regulate Fascin Phosphorylation Josephine C. Adams, James D. Clelland, Georgina D.M. Collett, Molecular Biology of the Cell	1999	125
Demyelination and single-carbon transfer pathway metabolites during the treatment of acute lymphoblastic leukemia: CSF studies. R. Surtees, James D. Clelland, I M Hann Journal of Clinical Oncology	1998	74
Efficacy of the Branched-Chain Amino Acids in the Treatment of Tardive Dyskinesia in Men Mary Richardson, Margaret Bevans, Laura L. Read, American Journal of Psychiatry	2003	74
Evidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcome Catherine L. Clelland, Laura L. Read, Amanda N. Baraldi, Schizophrenia Research PsychiatryPsychotic DisorderSchizophreniaNeuropsychiatryBiological Psychiatry	2011	73
Pulmonary artery pressure variation in patients with connective tissue disease: 24 hour ambulatory pulmonary artery pressure monitoring David Raeside, George Chalmers, James D. Clelland, Thorax	1998	66
Analysis of Plasma Biopterin Levels in Psychiatric Disorders Suggests a Common BH4 Deficit in Schizophrenia and Schizoaffective Disorder Mary Richardson, Laura L. Read, Margaret A. Reilly, Neurochemical Research Psychiatric DisordersPsychiatryPlasma Biopterin LevelsPsychotic DisorderSchizophrenia	2006	49
Evidence for a Tetrahydrobiopterin Deficit in Schizophrenia Mary Richardson, Laura L. Read, Catherine L. Clelland, Neuropsychobiology	2005	43
Analysis of the impact of antidepressants and other medications on COVID-19 infection risk in a chronic psychiatric in-patient cohort Catherine L. Clelland, Krista Ramiah, Louisa J. Steinberg, BJPsych Open	2021	43
Utilization of Never-Medicated Bipolar Disorder Patients towards Development and Validation of a Peripheral Biomarker Profile Catherine L. Clelland, Laura L. Read, Laura J. Panek, PLoS ONE Mental HealthGene Expression ProfilingSocial SciencesMood SymptomPsychiatric Genetics	2013	40
Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State–wide Psychiatric Hospital System Katlyn Nemani, Sharifa Z. Williams, Mark Olfson, JAMA Network Open	2022	37

Page 1